SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-004899
Filing Date
2010-01-26
Accepted
2010-01-26 18:31:39
Documents
1
Period of Report
2010-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3812
  Complete submission text file 0001209191-10-004899.txt   5609
Mailing Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Issuer) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12750 HIGH BLUFF DRIVE SUITE 310 SAN DIEGO CA 92130
Business Address
Raser Jeffrey (Reporting) CIK: 0001346901 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51665 | Film No.: 10548718